Literature DB >> 29085492

The expression and clinical significance of ZBTB7 in transitional cell carcinoma of the bladder.

Changcheng Guo1, Dabo Xiong1, Bin Yang1, Haiming Zhang1, Wenyu Gu1, Min Liu1, Xudong Yao1, Junhua Zheng1, Bo Peng1.   

Abstract

Zinc finger and BTB domain containing 7A (ZBTB7) is a ZBTB protein family member of transcriptional repressors that serves a critical role in cell transformation and malignancy. However, the association between ZBTB7 expression in bladder cancer tissues and the prognosis of patients remains unclear. The aim of the current study was to detect the expression of ZBTB7 in transitional cell carcinoma (TCC) of the bladder and normal bladder mucous tissues to evaluate the diagnostic and prognostic value of ZBTB7 in TCC of the bladder. A total of 100 TCC specimens were analyzed and the expression of ZBTB7 mRNA was examined via reverse transcription-quantitative polymerase chain reaction. The expression of ZBTB7 protein was examined by western blotting and immunohistochemistry. The association between ZBTB7 expression and the clinical prognosis of patients from the TCGA database was analyzed. High expression of ZBTB7 mRNA and protein in TCC tissue was detected and TCC expression was significantly higher in TCC tissue than in normal bladder mucous tissues (P<0.05). Furthermore, ZBTB7 expression was associated with recurrence, a larger tumor size and higher tumor grade. In terms of overall and recurrence-free survival, the group expressing high levels of ZBTB7 exhibited lower overall and recurrence-free survival compared with the low ZBTB7 expression group, although these differences were not statistically significant. Therefore, ZBTB7 may be important in the initiation and progression of TCC.

Entities:  

Keywords:  ZBTB7; prognosis; survival; transitional cell carcinoma of the bladder

Year:  2017        PMID: 29085492      PMCID: PMC5649710          DOI: 10.3892/ol.2017.6814

Source DB:  PubMed          Journal:  Oncol Lett        ISSN: 1792-1074            Impact factor:   2.967


  28 in total

1.  Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method.

Authors:  K J Livak; T D Schmittgen
Journal:  Methods       Date:  2001-12       Impact factor: 3.608

2.  Regulation of B versus T lymphoid lineage fate decision by the proto-oncogene LRF.

Authors:  Takahiro Maeda; Taha Merghoub; Robin M Hobbs; Lin Dong; Manami Maeda; Johannes Zakrzewski; Marcel R M van den Brink; Arthur Zelent; Hirokazu Shigematsu; Koichi Akashi; Julie Teruya-Feldstein; Giorgio Cattoretti; Pier Paolo Pandolfi
Journal:  Science       Date:  2007-05-11       Impact factor: 47.728

3.  Expression of the proto-oncogene Pokemon in colorectal cancer--inhibitory effects of an siRNA.

Authors:  Gan-Ting Zhao; Li-Juan Yang; Xi-Xia Li; Hui-Lin Cui; Rui Guo
Journal:  Asian Pac J Cancer Prev       Date:  2013

4.  International variations in bladder cancer incidence and mortality.

Authors:  Saurabh Chavan; Freddie Bray; Joannie Lortet-Tieulent; Michael Goodman; Ahmedin Jemal
Journal:  Eur Urol       Date:  2013-10-16       Impact factor: 20.096

5.  Depletion of Pokemon gene inhibits hepatocellular carcinoma cell growth through inhibition of H-ras.

Authors:  Quan-Le Zhang; De-An Tian; Xiang-Jiang Xu
Journal:  Onkologie       Date:  2011-09-23

6.  The effect of Pokemon on bladder cancer epithelial-mesenchymal transition.

Authors:  Changcheng Guo; Kai Zhu; Wei Sun; Bin Yang; Wenyu Gu; Jun Luo; Bo Peng; Junhua Zheng
Journal:  Biochem Biophys Res Commun       Date:  2014-01-03       Impact factor: 3.575

7.  Gene amplification is a relatively frequent event leading to ZBTB7A (Pokemon) overexpression in non-small cell lung cancer.

Authors:  K Apostolopoulou; I S Pateras; K Evangelou; P K Tsantoulis; M Liontos; C Kittas; D G Tiniakos; A Kotsinas; C Cordon-Cardo; V G Gorgoulis
Journal:  J Pathol       Date:  2007-11       Impact factor: 7.996

8.  Overexpression of Pokemon in non-small cell lung cancer and foreshowing tumor biological behavior as well as clinical results.

Authors:  Zhi-Hong Zhao; Sheng-Fa Wang; Liang Yu; Ju Wang; Hao Chang; Wei-Li Yan; Jian Zhang; Kai Fu
Journal:  Lung Cancer       Date:  2008-06-11       Impact factor: 5.705

9.  Expression of the Pokemon proto-oncogene in nasopharyngeal carcinoma cell lines and tissues.

Authors:  Wei Jiao; Fei Liu; Feng-Zhu Tang; Jiao Lan; Rui-Ping Xiao; Xing-Zhou Chen; Hui-Lan Ye; Yong-Lin Cai
Journal:  Asian Pac J Cancer Prev       Date:  2013

10.  Methylomics analysis identifies ZNF671 as an epigenetically repressed novel tumor suppressor and a potential non-invasive biomarker for the detection of urothelial carcinoma.

Authors:  Chia-Ming Yeh; Pi-Che Chen; Hsiao-Yen Hsieh; Yeong-Chin Jou; Chang-Te Lin; Ming-Hsuan Tsai; Wen-Yu Huang; Yi-Ting Wang; Ru-Inn Lin; Szu-Shan Chen; Chun-Liang Tung; Shu-Fen Wu; D Ching Chang; Cheng-Huang Shen; Cheng-Da Hsu; Michael W Y Chan
Journal:  Oncotarget       Date:  2015-10-06
View more
  4 in total

1.  Identification of key gene signatures for the overall survival of ovarian cancer.

Authors:  Akash Pawar; Oindrila Roy Chowdhury; Ruby Chauhan; Sanjay Talole; Atanu Bhattacharjee
Journal:  J Ovarian Res       Date:  2022-01-20       Impact factor: 4.234

2.  Decreased expression of SRY-box containing gene 30 is related to malignant phenotypes of human bladder cancer and correlates with poor prognosis.

Authors:  Yang Liu; Han Wang; Jianhua Zhong; Chenglong Wu; Gang Yang; Yuantang Zhong; Jinghua Zhang; Aifa Tang
Journal:  BMC Cancer       Date:  2018-06-07       Impact factor: 4.430

3.  Analysis of lncRNAs and mRNA Expression in the ZBTB1 Knockout Monoclonal EL4 Cell Line and Combined Analysis With miRNAs and circRNAs.

Authors:  Junhong Wang; Xiaoxu Li; Yiyuan Lu; Quntao Huang; Yu Sun; Mingyang Cheng; Fengdi Li; Chunwei Shi; Yan Zeng; Chunfeng Wang; Xin Cao
Journal:  Front Cell Infect Microbiol       Date:  2021-12-09       Impact factor: 5.293

4.  Nucleobindin 2 expression is an independent prognostic factor for bladder cancer.

Authors:  Jeong Man Cho; Kyong Tae Moon; Ho Jung Lee; Soon Cheol Shin; Jae Duck Choi; Jeong Yoon Kang; Tag Keun Yoo
Journal:  Medicine (Baltimore)       Date:  2020-03       Impact factor: 1.817

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.